Skip to main content
. 2017 Apr 20;11:100. doi: 10.3389/fncel.2017.00100

Figure 7.

Figure 7

Effects of ketamine on the level of brain-derived neurotrophic factor (BDNF) mRNA in the mPFC and HIP of IFS mice. IFS mice showed a decrease in Bdnf transcript covering its neuronal-specific promoter (exon IV) as well as in Bdnf transcript covering its protein-coding region (exon IX) in the mPFC and HIP. Long-term ketamine treatment increased the expression of exon-specific BDNF mRNA. Data are presented as mean ± SEM (n = 5 in per group). **P < 0.01, ***P < 0.001 compared with the Veh group; ###P < 0.001 compared with the IFS + Veh group.